APA aipamena

Glaser, A. P., Fantini, D., Wang, Y., Yu, Y., Rimar, K. J., Podojil, J. R., . . . Meeks, J. J. (2017). APOBEC-mediated mutagenesis in urothelial carcinoma is associated with improved survival, mutations in DNA damage response genes, and immune response. Oncotarget.

Chicago Style aipamena

Glaser, Alexander P., Damiano Fantini, Yiduo Wang, Yanni Yu, Kalen J. Rimar, Joseph R. Podojil, Stephen D. Miller, and Joshua J. Meeks. "APOBEC-mediated Mutagenesis in Urothelial Carcinoma Is Associated With Improved Survival, Mutations in DNA Damage Response Genes, and Immune Response." Oncotarget 2017.

MLA aipamena

Glaser, Alexander P., et al. "APOBEC-mediated Mutagenesis in Urothelial Carcinoma Is Associated With Improved Survival, Mutations in DNA Damage Response Genes, and Immune Response." Oncotarget 2017.

Kontuz: berrikusi erreferentzia hauek erabili aurretik.